09-04-2024 18:15
via
news.google.com
Galectin Therapeutics (NASDAQ:GALT) Earns "Buy" Rating from HC Wainwright - MarketBeat
Galectin Therapeutics (NASDAQ:GALT) Earns "Buy" Rating from HC Wainwright MarketBeat
Read more »